🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main purpose of this study is to investigate the efficacy of bevacizuma...
Status
Completed
Location
Department of Oncology, National Taiwan University Hospital
Start Date
2011-01
Trial ID
NCT01281696
Treatments Being Tested
Poorly differentiated neuroendocrine carcinomas (NEC) are a sub-group of ag...
Status
Completed
Location
Service d'Hépato-Gastroenterologie et Oncologie Digestive, Hôpital Sud, CHU d'Amiens
Start Date
2017-09-04
Trial ID
NCT02820857
Treatments Being Tested
This study adopts a novel strategy for first-line treatment of osteosarcoma...
Status
Completed
Location
Rady Children's Hospital and Health Center
Start Date
2008-06-03
Trial ID
NCT00667342
Treatments Being Tested
This single-arm, open-label, Phase II study assesses first-line QL1706 + be...
Status
Not Yet Recruiting
Location
National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, Beijing 100021
Start Date
2025-08-01
Trial ID
NCT07083375
Treatments Being Tested
Despite the fact that a substantial response rate may be obtained in small-...
Status
Completed
Location
Annemasse - CH
Start Date
2009-09
Trial ID
NCT00930891
This is a placebo-controlled, double-blind, multicenter, randomized study f...
Status
Completed
Location
Multiple Locations
Start Date
2007-03
Trial ID
NCT00403403
Treatments Being Tested
Recurrent or advanced cervical neuroendocrine carcinoma (NEC) is refractory...
Status
Unknown
Location
Lei Li
Start Date
2020-11-15
Trial ID
NCT04635956
Treatments Being Tested
Background: * Surgical resection is the treatment of choice for patients w...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2009-03
Trial ID
NCT00924209
Treatments Being Tested
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Completed
Location
Multiple Locations
Start Date
2006-10
Trial ID
NCT00387699
Treatments Being Tested
The primary objective of A-PLUS trial is to evaluate and compare the effica...
Status
Unknown
Location
Kaohsiung Chang Gung Memorial Hospital
Start Date
2014-04-21
Trial ID
NCT02185352
Treatments Being Tested